Evaluation of the percutaneous absorption of promethazine hydrochloride, In Vitro, using the human Ex Vivo skin model

International Journal of Pharmaceutical Compounding

Volumn 12, Issue 3, 2008, Pages 270-273

  Bassani, August S ^a   Banov, Daniel ^a   Lehman, Paul A ^b  

^a Professional Compounding Centers of America   (United States)

^b Cetero Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG VEHICLE; PROMETHAZINE;

ARTICLE; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG STRUCTURE; HUMAN; HUMAN TISSUE; STRATUM CORNEUM;

EID: 77949362440     PISSN: 10924221     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Burnham R, Gregg R, Healy P et al. The effectiveness of topical diclofenac for lateral epicondylitis. Clin J Sport Med 1998; 8(2): 78-81.
2. Lambert JD, Kim DH, Zheng R et al. Transdermal delivery of (-)-epigallocate-chin-3-gallate, a green tea polyphenol, in mice. J Pharm Pharmacol 2006; 58(5): 599-604.
3. Ghosh TK, Pfister WR, Yum SI, eds. Transdermal and Topical Drug Delivery Systems. Buffalo Grove, IL: Interpharm Press, Inc.; 1997: 1-9.
4. Franz TJ. Percutaneous absorption on the relevance of in vitro data. J Invest Dermatol 1975; 64(3): 190-195.
5. Franz TJ. The finite dose technique as a valid in vitro model for the study of percutaneous absorption in man. Curr Probl Dermatol 1978; 7: 58-68.
6. Franz TJ, Lehman PA. The use of water permeability as a means of validation for skin integrity in in vitro percutaneous absorption studies. J Invest Dermatol 1990; 95: 525.